デフォルト表紙
市場調査レポート
商品コード
1475914

尿道拡張器市場：地域（北米、欧州、アジア太平洋、ラテンアメリカ、中東アフリカ）別世界の産業分析、規模、シェア、成長、動向、2024-2032年予測

Urethral Dilators Market by Product Type, End-Users, and Geography (North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2032

出版日
ページ情報
英文 333 Pages
納期
2～5営業日
カスタマイズ可能
尿道拡張器市場：地域（北米、欧州、アジア太平洋、ラテンアメリカ、中東アフリカ）別世界の産業分析、規模、シェア、成長、動向、2024-2032年予測
出版日: 2024年05月02日
発行: Persistence Market Research
ページ情報: 英文 333 Pages
納期: 2～5営業日
GIIご利用のメリット

  • 全表示

  • 概要
  • 目次
概要

Persistence Market Research社の尿道拡張器市場レポートでは、2024年から2032年にかけての市場力学、成長要因、課題、新興動向などを包括的に分析しています。尿道拡張器市場の現状と将来展望に関する洞察を提供します。

尿道拡張器の世界市場は、2024年の2億4,800万米ドルから2032年には3億9,300万米ドルへと、CAGR5.5％で成長すると予測されます。

主な洞察

  • 推定市場規模（2024年）：2億4,800万米ドル
  • 予測市場規模（2032年）：3億9,300万米ドル
  • 世界市場成長率（CAGR 2024年～2032年）：5.5%

尿道拡張器市場：調査範囲

尿道拡張器は、診断および治療手順の両方で尿道の拡張に使用される医療機器です。本レポートでは、泌尿器疾患の有病率の上昇、低侵襲処置の技術進歩、患者の意識の高まりなど、尿道拡張器の需要増加の主な要因について概説しています。

市場成長の促進要因：

市場の成長はいくつかの要因によってもたらされます。まず、尿道狭窄、前立腺肥大症（BPH）、尿閉などの泌尿器疾患の有病率の増加が、尿道拡張、カテーテル治療、ステント留置などの診断・治療介入を目的とした尿道拡張器の需要を促進しています。さらに、操作性、潤滑性、生体適合性が改善された柔軟で親水性の尿道拡張器の開発を含む医療機器技術の進歩は、手技の安全性、有効性、患者の快適性を向上させ、泌尿器科診療における採用を促進しています。さらに、高齢者人口の増加、医療費の増加、新興市場における泌尿器科医療へのアクセスの拡大は、高齢化社会と世界の泌尿器科疾患の負担に伴って尿道拡張器の需要が増加するため、市場の成長に寄与しています。

市場の抑制要因：

見通しは明るいもの、尿道拡張器市場は一定の課題に直面しています。限られた保険償還範囲、規制上の制約、尿道拡張処置に伴う処置上のリスクなどの要因は、特に資源が乏しいヘルスケア環境および十分なサービスを受けていない患者集団において、尿道拡張器の市場成長および採用率を阻害する可能性があります。さらに、再利用可能な尿道拡張器具に関連する感染管理、滅菌プロトコル、交差汚染のリスクに関する懸念は、医療従事者の嗜好や購買決定に影響を与え、再利用可能な代替品よりも使い捨ての使い捨て器具を好む可能性があります。さらに、内視鏡手術、レーザー治療、尿道ステント留置術などの代替治療法が利用可能になることで、競争圧力や代替リスクが生じ、尿道拡張器市場の市場力学や製品需要に影響を与える可能性があります。

市場機会：

尿道拡張器市場には技術革新と市場拡大の大きな機会があります。メーカーは、特定の臨床適応症、解剖学的変化、患者の嗜好に合わせた特殊な尿道拡張器の開発に注力し、多様な泌尿器科手術や患者集団に対応することができます。例えば、親水性コーティングを施した尿道拡張器は、摩擦の低減、潤滑性の向上、尿道通過の円滑化などの利点を提供し、尿道拡張処置を受ける患者の外傷や不快感を最小限に抑えます。さらに、泌尿器科クリニック、病院、外来手術センターとの戦略的パートナーシップ、提携、販売契約は、新しい地域や顧客セグメントへの市場浸透と拡大を促進します。さらに、研究開発、臨床研究、規制当局の承認への投資により、企業は統合された可視化システム、温度監視センサー、リアルタイムフィードバック機構などの高度な機能を備えた革新的な尿道拡張器を発売することができ、尿道拡張市場における処置の結果、患者の安全性、医療従事者の満足度を高めることができます。

本レポートで扱う主な質問

  • 2024年から2032年までの尿道拡張器市場の予想CAGRは？
  • 尿道拡張器市場の成長を促進する主な要因は何か？
  • 尿道拡張器のどのタイプが最大の市場シェアを占めているか？
  • 尿道拡張器の世界市場における主要プレーヤーは？
  • 尿道拡張器市場で競合を維持するために主要企業はどのような戦略を採用しているか？

目次

第1章 エグゼクティブサマリー

第2章 市場概要

  • 市場範囲/分類
  • 市場の定義/範囲/制限

第3章 市場背景

  • 市場力学
  • シナリオ予測
  • 機会マップ分析
  • 投資実現可能性マトリックス
  • PESTLEとポーター分析
  • 規制状況
  • 地域親市場見通し

第4章 世界の尿道拡張器市場分析

  • 過去の市場規模（金額）分析、2019-2023年
  • 現在および将来の市場規模（金額）予測、2024～2032年

第5章 世界の尿道拡張器市場分析、使用別

  • イントロダクション/主な調査結果
  • 過去の市場規模（金額）分析、2019～2023年
  • 現在および将来の市場規模（金額）分析と予測、2024～2032年
    • 使い捨て
    • 再利用可能
  • 使用別前年比成長動向分析、2019～2023年
  • 使用別絶対的収益の機会分析、2024～2032年

第6章 世界の尿道拡張器市場分析、用途別

  • イントロダクション/主な調査結果
  • 過去の市場規模（金額）分析、2019～2023年
  • 現在および将来の市場規模（金額）分析と予測、2024～2032年
    • 尿道狭窄
    • 外尿道狭窄
    • 腎臓結石除去
    • その他
  • 用途別前年比成長動向分析、2019～2023年
  • 用途別絶対的収益の機会分析、2024～2032年

第7章 世界の尿道拡張器市場分析、エンドユーザー別

  • イントロダクション/主な調査結果
  • 過去の市場規模（金額）分析、2019～2023年
  • 現在および将来の市場規模（金額）分析と予測、2024～2032年
    • 病院
    • クリニック
    • 外来手術センター
    • 在宅ケア環境
  • エンドユーザー別前年比成長動向分析、2019～2023年
  • エンドユーザー別絶対的収益の機会分析、2024-2032

第8章 世界の尿道拡張器市場分析、地域別

  • イントロダクション
  • 過去の市場規模（金額）分析、2019～2023年
  • 現在の市場規模（金額）分析と予測、2024～2032年
    • 北米
    • ラテンアメリカ
    • 欧州
    • アジア太平洋地域
    • 中東・アフリカ
  • 地域別市場魅力度分析

第9章 北米の尿道拡張器市場分析、国別

第10章 ラテンアメリカの尿道拡張器市場分析、国別

第11章 欧州の尿道拡張器市場分析、国別

第12章 アジア太平洋地域の尿道拡張器市場分析、国別

第13章 MEA尿道拡張器市場分析、国別

第14章 主要国の尿道拡張器市場分析

  • 米国
  • カナダ
  • ブラジル
  • メキシコ
  • ドイツ
  • 英国
  • フランス
  • スペイン
  • イタリア
  • 中国
  • 日本
  • 韓国
  • シンガポール
  • タイ
  • インドネシア
  • オーストラリア
  • ニュージーランド
  • GCC諸国
  • 南アフリカ
  • イスラエル

第15章 市場構造分析

  • 競合ダッシュボード
  • 競合ベンチマーク
  • 主要企業の市場シェア分析

第16章 競合分析

  • 競合の詳細
    • B. Braun Melsungen AG
    • BD
    • Cook Medical
    • Med Pro Medical BV
    • Teleflex Inc.
    • Boston Scientific Corporation
    • ICU Medical
    • Urovision-Urotech
    • Coloplast
    • ACE Medical Devices Pvt. Ltd.

第17章 使用される前提条件と頭字語

第18章 調査手法

目次
Product Code: PMRREP33185

The Urethral Dilators Market report by Persistence Market Research provides a comprehensive analysis of market dynamics, growth factors, challenges, and emerging trends from 2024 to 2032. It offers insights into the current state and future outlook of the Urethral Dilators Market.

The global urethral dilators market is projected to grow at a compound annual growth rate (CAGR) of 5.5% from USD 248 million in 2024 to USD 393 million by 2032.

Key Insights:

  • Estimated Market Size (2024): USD 248 Million
  • Projected Market Size (2032): USD 393 Million
  • Global Market Growth Rate (CAGR 2024 to 2032): 5.5%

Urethral Dilators Market - Report Scope:

Urethral dilators are medical devices used for the dilation of the urethra in both diagnostic and therapeutic procedures. The report outlines key drivers behind the increasing demand for urethral dilators, including the rising prevalence of urological disorders, technological advancements in minimally invasive procedures, and growing patient awareness.

Market Growth Drivers:

The market's growth is driven by several factors. Firstly, the increasing prevalence of urological conditions such as urethral strictures, benign prostatic hyperplasia (BPH), and urinary retention fuels demand for urethral dilators for diagnostic and therapeutic interventions, including urethral dilation, catheterization, and stent placement. Additionally, advancements in medical device technology, including the development of flexible and hydrophilic urethral dilators with improved maneuverability, lubricity, and biocompatibility, enhance procedural safety, efficacy, and patient comfort, driving adoption in urological practice. Moreover, the growing geriatric population, rising healthcare expenditures, and expanding access to urological care in emerging markets contribute to market growth, as demand for urethral dilators increases with the aging population and the burden of urological diseases worldwide.

Market Restraints:

Despite the positive outlook, the Urethral Dilators Market faces certain challenges. Factors such as limited reimbursement coverage, regulatory constraints, and procedural risks associated with urethral dilation procedures may hinder market growth and adoption rates of urethral dilators, particularly in resource-constrained healthcare settings and underserved patient populations. Moreover, concerns regarding infection control, sterilization protocols, and cross-contamination risks associated with reusable urethral dilators may influence healthcare provider preferences and purchasing decisions, favoring single-use disposable devices over reusable alternatives. Additionally, the availability of alternative treatment modalities, including endoscopic surgery, laser therapy, and urethral stenting, may pose competitive pressures and alternative treatment modalities, including endoscopic surgery, laser therapy, and urethral stenting, may pose competitive pressures and substitution risks, affecting market dynamics and product demand in the urethral dilators market.

Market Opportunities:

The Urethral Dilators Market offers significant opportunities for innovation and market expansion. Manufacturers can focus on developing specialized urethral dilators tailored to specific clinical indications, anatomical variations, and patient preferences, catering to diverse urological procedures and patient populations. For instance, hydrophilic-coated urethral dilators offer advantages such as reduced friction, enhanced lubrication, and smoother passage through the urethra, minimizing trauma and discomfort for patients undergoing urethral dilation procedures. Moreover, strategic partnerships, collaborations, and distribution agreements with urology clinics, hospitals, and ambulatory surgery centers facilitate market penetration and expansion into new geographic regions and customer segments. Furthermore, investments in research and development, clinical studies, and regulatory approvals enable companies to launch innovative urethral dilators with advanced features, such as integrated visualization systems, temperature monitoring sensors, and real-time feedback mechanisms, enhancing procedural outcomes, patient safety, and healthcare provider satisfaction in the urethral dilation market.

Key Questions Addressed in the Report:

  • What is the Expected CAGR of the Urethral Dilators Market from 2024 to 2032?
  • What are the Key Factors Driving the Growth of the Urethral Dilators Market?
  • Which Type of Urethral Dilator Holds the Largest Market Share?
  • Who are the Key Players in the Global Urethral Dilators Market?
  • What Strategies are Adopted by Leading Companies to Stay Competitive in the Urethral Dilators Market?

Competitive Landscape and Business Strategies:

Key players in the Urethral Dilators Market include Boston Scientific Corporation, Cook Medical LLC, Teleflex Incorporated, ROCAMED, and Olympus Corporation, among others. These companies focus on product innovation, portfolio expansion, and strategic acquisitions to maintain a competitive edge in the market. For instance, Boston Scientific Corporation offers a range of urethral dilators for urological procedures, including balloon dilation catheters, metal dilators, and filiform followers, while Cook Medical LLC specializes in hydrophilic-coated urethral dilators and urethral access sheaths for endourological applications. Market players also invest in professional education, training programs, and customer support services to enhance clinical proficiency, procedural efficiency, and patient outcomes in the urethral dilation market.

Key Companies Profiled:

  • B. Braun Melsungen AG
  • BD
  • Cook Medical
  • MED pro Medical BV
  • Teleflex Inc.
  • UROMED
  • Boston Scientific Corporation
  • Smiths Medical (ICU Medical)
  • Urovision-Urotech
  • Coloplast

Urethral Dilators Market Segmentation:

Urethral Dilators Market by Usage

  • Disposable
  • Reusable

Urethral Dilators Market by Application

  • Urethral Stricture
  • Meatal Stenosis
  • Kidney Stone Removal
  • Others

Urethral Dilators by End User

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centre
  • Home Care Settings
  • Others

Urethral Dilators Market by Region

  • North America Market
  • Europe Market
  • East Asia Market
  • South Asia and Pacific Market
  • Middle East & Africa Market
  • South America Market

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand-side Trends
  • 1.3. Supply-side Trends
  • 1.4. Technology Roadmap Analysis
  • 1.5. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations

3. Market Background

  • 3.1. Market Dynamics
    • 3.1.1. Drivers
    • 3.1.2. Restraints
    • 3.1.3. Opportunity
    • 3.1.4. Trends
  • 3.2. Scenario Forecast
    • 3.2.1. Demand in Optimistic Scenario
    • 3.2.2. Demand in Likely Scenario
    • 3.2.3. Demand in Conservative Scenario
  • 3.3. Opportunity Map Analysis
  • 3.4. Investment Feasibility Matrix
  • 3.5. PESTLE and Porter's Analysis
  • 3.6. Regulatory Landscape
    • 3.6.1. By Key Regions
    • 3.6.2. By Key Countries
  • 3.7. Regional Parent Market Outlook

4. Global Urethral Dilators Market Analysis 2019-2023 and Forecast, 2024-2032

  • 4.1. Historical Market Size Value (US$ Mn) Analysis, 2019-2023
  • 4.2. Current and Future Market Size Value (US$ Mn) Projections, 2024-2032
    • 4.2.1. Y-o-Y Growth Trend Analysis
    • 4.2.2. Absolute $ Opportunity Analysis

5. Global Urethral Dilators Market Analysis 2019-2023 and Forecast 2024-2032, By Usage

  • 5.1. Introduction / Key Findings
  • 5.2. Historical Market Size Value (US$ Mn) Analysis By Usage, 2019-2023
  • 5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Usage, 2024-2032
    • 5.3.1. Disposable
    • 5.3.2. Reusable
  • 5.4. Y-o-Y Growth Trend Analysis By Usage, 2019-2023
  • 5.5. Absolute $ Opportunity Analysis By Usage, 2024-2032

6. Global Urethral Dilators Market Analysis 2019-2023 and Forecast 2024-2032, By Application

  • 6.1. Introduction / Key Findings
  • 6.2. Historical Market Size Value (US$ Mn) Analysis By Application, 2019-2023
  • 6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Application, 2024-2032
    • 6.3.1. Urethral Stricture
    • 6.3.2. Meatal Stenosis
    • 6.3.3. Kidney Stone Removal
    • 6.3.4. Others
  • 6.4. Y-o-Y Growth Trend Analysis By Application, 2019-2023
  • 6.5. Absolute $ Opportunity Analysis By Application, 2024-2032

7. Global Urethral Dilators Market Analysis 2019-2023 and Forecast 2024-2032, By End-user

  • 7.1. Introduction / Key Findings
  • 7.2. Historical Market Size Value (US$ Mn) Analysis By End-user , 2019-2023
  • 7.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By End-user , 2024-2032
    • 7.3.1. Hospitals
    • 7.3.2. Clinics
    • 7.3.3. Ambulatory Surgical Center
    • 7.3.4. Home Care Settings
  • 7.4. Y-o-Y Growth Trend Analysis By End-user , 2019-2023
  • 7.5. Absolute $ Opportunity Analysis By End-user , 2024-2032

8. Global Urethral Dilators Market Analysis 2019-2023 and Forecast 2024-2032, By Region

  • 8.1. Introduction
  • 8.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2019-2023
  • 8.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2024-2032
    • 8.3.1. North America
    • 8.3.2. Latin America
    • 8.3.3. Europe
    • 8.3.4. Asia Pacific
    • 8.3.5. MEA
  • 8.4. Market Attractiveness Analysis By Region

9. North America Urethral Dilators Market Analysis 2019-2023 and Forecast 2024-2032, By Country

  • 9.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 9.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2024-2032
    • 9.2.1. By Country
      • 9.2.1.1. U.S.
      • 9.2.1.2. Canada
    • 9.2.2. By Usage
    • 9.2.3. By Application
    • 9.2.4. By End-user
  • 9.3. Market Attractiveness Analysis
    • 9.3.1. By Country
    • 9.3.2. By Usage
    • 9.3.3. By Application
    • 9.3.4. By End-user
  • 9.4. Key Takeaways

10. Latin America Urethral Dilators Market Analysis 2019-2023 and Forecast 2024-2032, By Country

  • 10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2024-2032
    • 10.2.1. By Country
      • 10.2.1.1. Brazil
      • 10.2.1.2. Mexico
      • 10.2.1.3. Rest of Latin America
    • 10.2.2. By Usage
    • 10.2.3. By Application
    • 10.2.4. By End-user
  • 10.3. Market Attractiveness Analysis
    • 10.3.1. By Country
    • 10.3.2. By Usage
    • 10.3.3. By Application
    • 10.3.4. By End-user
  • 10.4. Key Takeaways

11. Europe Urethral Dilators Market Analysis 2019-2023 and Forecast 2024-2032, By Country

  • 11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2024-2032
    • 11.2.1. By Country
      • 11.2.1.1. Germany
      • 11.2.1.2. U.K.
      • 11.2.1.3. France
      • 11.2.1.4. Spain
      • 11.2.1.5. Italy
      • 11.2.1.6. Rest of Europe
    • 11.2.2. By Usage
    • 11.2.3. By Application
    • 11.2.4. By End-user
  • 11.3. Market Attractiveness Analysis
    • 11.3.1. By Country
    • 11.3.2. By Usage
    • 11.3.3. By Application
    • 11.3.4. By End-user
  • 11.4. Key Takeaways

12. Asia Pacific Urethral Dilators Market Analysis 2019-2023 and Forecast 2024-2032, By Country

  • 12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2024-2032
    • 12.2.1. By Country
      • 12.2.1.1. China
      • 12.2.1.2. Japan
      • 12.2.1.3. South Korea
      • 12.2.1.4. Singapore
      • 12.2.1.5. Thailand
      • 12.2.1.6. Indonesia
      • 12.2.1.7. Australia
      • 12.2.1.8. New Zealand
      • 12.2.1.9. Rest of Asia Pacific
    • 12.2.2. By Usage
    • 12.2.3. By Application
    • 12.2.4. By End-user
  • 12.3. Market Attractiveness Analysis
    • 12.3.1. By Country
    • 12.3.2. By Usage
    • 12.3.3. By Application
    • 12.3.4. By End-user
  • 12.4. Key Takeaways

13. MEA Urethral Dilators Market Analysis 2019-2023 and Forecast 2024-2032, By Country

  • 13.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
  • 13.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2024-2032
    • 13.2.1. By Country
      • 13.2.1.1. GCC Countries
      • 13.2.1.2. South Africa
      • 13.2.1.3. Israel
      • 13.2.1.4. Rest of MEA
    • 13.2.2. By Usage
    • 13.2.3. By Application
    • 13.2.4. By End-user
  • 13.3. Market Attractiveness Analysis
    • 13.3.1. By Country
    • 13.3.2. By Usage
    • 13.3.3. By Application
    • 13.3.4. By End-user
  • 13.4. Key Takeaways

14. Key Countries Urethral Dilators Market Analysis

  • 14.1. U.S.
    • 14.1.1. Pricing Analysis
    • 14.1.2. Market Share Analysis, 2023
      • 14.1.2.1. By Usage
      • 14.1.2.2. By Application
      • 14.1.2.3. By End-user
  • 14.2. Canada
    • 14.2.1. Pricing Analysis
    • 14.2.2. Market Share Analysis, 2023
      • 14.2.2.1. By Usage
      • 14.2.2.2. By Application
      • 14.2.2.3. By End-user
  • 14.3. Brazil
    • 14.3.1. Pricing Analysis
    • 14.3.2. Market Share Analysis, 2023
      • 14.3.2.1. By Usage
      • 14.3.2.2. By Application
      • 14.3.2.3. By End-user
  • 14.4. Mexico
    • 14.4.1. Pricing Analysis
    • 14.4.2. Market Share Analysis, 2023
      • 14.4.2.1. By Usage
      • 14.4.2.2. By Application
      • 14.4.2.3. By End-user
  • 14.5. Germany
    • 14.5.1. Pricing Analysis
    • 14.5.2. Market Share Analysis, 2023
      • 14.5.2.1. By Usage
      • 14.5.2.2. By Application
      • 14.5.2.3. By End-user
  • 14.6. U.K.
    • 14.6.1. Pricing Analysis
    • 14.6.2. Market Share Analysis, 2023
      • 14.6.2.1. By Usage
      • 14.6.2.2. By Application
      • 14.6.2.3. By End-user
  • 14.7. France
    • 14.7.1. Pricing Analysis
    • 14.7.2. Market Share Analysis, 2023
      • 14.7.2.1. By Usage
      • 14.7.2.2. By Application
      • 14.7.2.3. By End-user
  • 14.8. Spain
    • 14.8.1. Pricing Analysis
    • 14.8.2. Market Share Analysis, 2023
      • 14.8.2.1. By Usage
      • 14.8.2.2. By Application
      • 14.8.2.3. By End-user
  • 14.9. Italy
    • 14.9.1. Pricing Analysis
    • 14.9.2. Market Share Analysis, 2023
      • 14.9.2.1. By Usage
      • 14.9.2.2. By Application
      • 14.9.2.3. By End-user
  • 14.10. China
    • 14.10.1. Pricing Analysis
    • 14.10.2. Market Share Analysis, 2023
      • 14.10.2.1. By Usage
      • 14.10.2.2. By Application
      • 14.10.2.3. By End-user
  • 14.11. Japan
    • 14.11.1. Pricing Analysis
    • 14.11.2. Market Share Analysis, 2023
      • 14.11.2.1. By Usage
      • 14.11.2.2. By Application
      • 14.11.2.3. By End-user
  • 14.12. South Korea
    • 14.12.1. Pricing Analysis
    • 14.12.2. Market Share Analysis, 2023
      • 14.12.2.1. By Usage
      • 14.12.2.2. By Application
      • 14.12.2.3. By End-user
  • 14.13. Singapore
    • 14.13.1. Pricing Analysis
    • 14.13.2. Market Share Analysis, 2023
      • 14.13.2.1. By Usage
      • 14.13.2.2. By Application
      • 14.13.2.3. By End-user
  • 14.14. Thailand
    • 14.14.1. Pricing Analysis
    • 14.14.2. Market Share Analysis, 2023
      • 14.14.2.1. By Usage
      • 14.14.2.2. By Application
      • 14.14.2.3. By End-user
  • 14.15. Indonesia
    • 14.15.1. Pricing Analysis
    • 14.15.2. Market Share Analysis, 2023
      • 14.15.2.1. By Usage
      • 14.15.2.2. By Application
      • 14.15.2.3. By End-user
  • 14.16. Australia
    • 14.16.1. Pricing Analysis
    • 14.16.2. Market Share Analysis, 2023
      • 14.16.2.1. By Usage
      • 14.16.2.2. By Application
      • 14.16.2.3. By End-user
  • 14.17. New Zealand
    • 14.17.1. Pricing Analysis
    • 14.17.2. Market Share Analysis, 2023
      • 14.17.2.1. By Usage
      • 14.17.2.2. By Application
      • 14.17.2.3. By End-user
  • 14.18. GCC Countries
    • 14.18.1. Pricing Analysis
    • 14.18.2. Market Share Analysis, 2023
      • 14.18.2.1. By Usage
      • 14.18.2.2. By Application
      • 14.18.2.3. By End-user
  • 14.19. South Africa
    • 14.19.1. Pricing Analysis
    • 14.19.2. Market Share Analysis, 2023
      • 14.19.2.1. By Usage
      • 14.19.2.2. By Application
      • 14.19.2.3. By End-user
  • 14.20. Israel
    • 14.20.1. Pricing Analysis
    • 14.20.2. Market Share Analysis, 2023
      • 14.20.2.1. By Usage
      • 14.20.2.2. By Application
      • 14.20.2.3. By End-user

15. Market Structure Analysis

  • 15.1. Competition Dashboard
  • 15.2. Competition Benchmarking
  • 15.3. Market Share Analysis of Top Players
    • 15.3.1. By Regional
    • 15.3.2. By Usage
    • 15.3.3. By Application
    • 15.3.4. By End-user

16. Competition Analysis

  • 16.1. Competition Deep Dive
    • 16.1.1. B. Braun Melsungen AG
      • 16.1.1.1. Overview
      • 16.1.1.2. Product Portfolio
      • 16.1.1.3. Profitability by Market Segments
      • 16.1.1.4. Sales Footprint
      • 16.1.1.5. Strategy Overview
        • 16.1.1.5.1. Marketing Strategy
    • 16.1.2. BD
      • 16.1.2.1. Overview
      • 16.1.2.2. Product Portfolio
      • 16.1.2.3. Profitability by Market Segments
      • 16.1.2.4. Sales Footprint
      • 16.1.2.5. Strategy Overview
        • 16.1.2.5.1. Marketing Strategy
    • 16.1.3. Cook Medical
      • 16.1.3.1. Overview
      • 16.1.3.2. Product Portfolio
      • 16.1.3.3. Profitability by Market Segments
      • 16.1.3.4. Sales Footprint
      • 16.1.3.5. Strategy Overview
        • 16.1.3.5.1. Marketing Strategy
    • 16.1.4. Med Pro Medical B.V.
      • 16.1.4.1. Overview
      • 16.1.4.2. Product Portfolio
      • 16.1.4.3. Profitability by Market Segments
      • 16.1.4.4. Sales Footprint
      • 16.1.4.5. Strategy Overview
        • 16.1.4.5.1. Marketing Strategy
    • 16.1.5. Teleflex Inc.
      • 16.1.5.1. Overview
      • 16.1.5.2. Product Portfolio
      • 16.1.5.3. Profitability by Market Segments
      • 16.1.5.4. Sales Footprint
      • 16.1.5.5. Strategy Overview
        • 16.1.5.5.1. Marketing Strategy
    • 16.1.6. Boston Scientific Corporation
      • 16.1.6.1. Overview
      • 16.1.6.2. Product Portfolio
      • 16.1.6.3. Profitability by Market Segments
      • 16.1.6.4. Sales Footprint
      • 16.1.6.5. Strategy Overview
        • 16.1.6.5.1. Marketing Strategy
    • 16.1.7. ICU Medical
      • 16.1.7.1. Overview
      • 16.1.7.2. Product Portfolio
      • 16.1.7.3. Profitability by Market Segments
      • 16.1.7.4. Sales Footprint
      • 16.1.7.5. Strategy Overview
        • 16.1.7.5.1. Marketing Strategy
    • 16.1.8. Urovision-Urotech
      • 16.1.8.1. Overview
      • 16.1.8.2. Product Portfolio
      • 16.1.8.3. Profitability by Market Segments
      • 16.1.8.4. Sales Footprint
      • 16.1.8.5. Strategy Overview
        • 16.1.8.5.1. Marketing Strategy
    • 16.1.9. Coloplast
      • 16.1.9.1. Overview
      • 16.1.9.2. Product Portfolio
      • 16.1.9.3. Profitability by Market Segments
      • 16.1.9.4. Sales Footprint
      • 16.1.9.5. Strategy Overview
        • 16.1.9.5.1. Marketing Strategy
    • 16.1.10. ACE Medical Devices Pvt. Ltd.
      • 16.1.10.1. Overview
      • 16.1.10.2. Product Portfolio
      • 16.1.10.3. Profitability by Market Segments
      • 16.1.10.4. Sales Footprint
      • 16.1.10.5. Strategy Overview
        • 16.1.10.5.1. Marketing Strategy

17. Assumptions & Acronyms Used

18. Research Methodology